Drugmakers may have to disclose prices of medicine in television ads image

Washington Post, October 15, 2018
Amy Goldstein and Carolyn Y Johnson, quoting Rachel Sachs


Read the full article

From the article:

Rachel Sachs, an associate professor of law at Washington University in St. Louis School of Law, said that it is unclear how or why disclosures would reduce drug prices. “The administration has not yet advanced a theory for how that’s likely to happen, and we’ve seen many times that shaming companies for their high prices publicly doesn’t cause them to lower their prices.”

Read more here!

fda pharmaceuticals rachel sachs regulation